ESG investing: 3 UK shares I’d consider

Looking for shares to buy now from an ESG investing perspective, Christopher Ruane weighs the investment case for three UK stocks.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

ESG investing has become more popular as investors consider the environmental, social, and governance aspects of their holdings. The idea of ESG investing may sound appealing. But in practice there is no agreed standard of what constitutes an ESG share.

Here are three shares I think have at least some ESG credentials. I consider whether I would add them to my portfolio – but only one attracts me right now.

Access to medicine leader

Well-known pharma giant GlaxoSmithKline (LSE: GSK) is often prominent on lists ranking shares by their ESG credentials. That is because of the company’s focus on broadening access to medicine. The company came top out of 20 pharma companies assessed in this year’s Access to Medicine Index. GSK’s pipeline includes drugs targeting priority diseases prevalent in poorer countries.

That may give GSK some credibility when it comes to ESG investing. But I feel the investment case for the company is more mixed. The relative weakness of its pipeline has worried analysts in recent years. The dividend of 5.6% is attractive for a FTSE 100 stalwart. But the company has indicated that it may effectively reduce the dividend after the imminent spin-off of its consumer division.

Despite improving steadily since the start of March, the GSK share price is still down 14% over the past year. That reflects investor nervousness about the strategic listlessness of the company and its pipeline. The spin-off could help bring more focus – but that isn’t guaranteed. I’m tempted by the yield, but for now am sitting out GSK to see how the spin-off goes.

ESG investing in recycling

Shares in recycling service providers are an obvious candidate for ESG investing. Should I consider buying shares in Augean (LSE: AUG), which specialises in hazardous waste management? From landfill sites to decommissioned oil rigs, Augean is involved in activities including waste treatment and recycling.

There has been talk of a possible bid for Augean. The deadline for a firm bid expired last week but has now been extended to next month. The Augean share price is up 59% in the past year. Augean shares now trade on a price-to-earnings ratio of almost 20.

I think the company has growth potential due to its specialist expertise at a time of heightening environmental standards. But after an increase following the news of a possible bid, I wouldn’t add the shares to my portfolio right now. If a bid doesn’t materialise, the shares risk returning to where they were before bid speculation emerged.

Closed loop recycling

Another company involved in recycling is paper and packaging firm D S Smith (LSE: SMDS). From an ESG investing perspective, its closed loop approach to recycling offers environmental benefits.

I also like D S Smith’s business performance and strategic focus. Last year, revenue and post-tax profits both fell due to the pandemic. But demand for packaging has surged due to an increase in online shopping. With its well-established operations in Europe and North America, D S Smith should benefit from that. The demand surge also poses a risk, though, as material prices have moved sharply up – something the company flagged in its results last week. That could hurt profit margins.

But with its proven ability to profit from paper and packaging, I would consider buying D S Smith for my portfolio.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Christopher Ruane has no shares in any company mentioned. The Motley Fool UK has recommended DS Smith and GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

How many BT shares would I need to earn a £10,000 second income?

A 5.76% dividend yield is attractive, and if BT manages to bring down its costs, it might be a great…

Read more »

Black woman using loudspeaker to be heard
Dividend Shares

Here are 2 of my top shares to buy if we get a stock market crash this summer

Jon Smith reveals two stocks on his watchlist of shares to buy if we see the market move lower in…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

All-time high! Could putting £900 a month into FTSE 100 shares make me a millionaire?

By putting under £1,000 each month into carefully chosen FTSE 100 shares, this writer thinks he could become a millionaire…

Read more »

Dividend Shares

A 12% yield? Here’s the dividend forecast for a hot income stock

Jon Smith considers a FTSE 250 income stock that has a clear dividend policy with the aim of paying out…

Read more »

Happy couple showing relief at news
Investing Articles

£5,000 in savings? Here’s how I’d try and turn that into a £308 monthly passive income

It's possible to create a lifelong passive income stream from a well-chosen portfolio of dividend shares. Here's how I'd invest…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Value Shares

This £3 value stock could soar in the AI boom

This under-the-radar value stock could do well on the back of the huge global build-out of data centres in the…

Read more »

Growth Shares

Should I invest in Darktrace shares as they rocket towards £6?

Darktrace shares are up nearly 75% in 2024 as the cybersecurity sector rallied, but is it too late to invest?…

Read more »

Front view photo of a woman using digital tablet in London
Investing Articles

Up 33% in 3 months but Lloyds shares still look undervalued to me

Lloyds shares are finally in demand after a tough few years. While they're more expensive than they were, Harvey Jones…

Read more »